Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 13 to 24 of 132 entries
Sorted by: Best Match Show Resources per page
Multinucleon effects in muon capture on 3He at high energy transfer.

Physical review. C, Nuclear physics

Chung KS, Congleton JG, Cummings WJ, Dodge GE, Hanna SS, Helmer R, King BH, King BE, Kuhn SE, Lee YK, Lee JM, Mason GR, Rosenzweig DP, Schubank RB, Shin YM, Stevenson NR, Wienands U.
PMID: 9969852
Phys Rev C Nucl Phys. 1994 Oct;50(4):1771-1786. doi: 10.1103/physrevc.50.1771.

No abstract available.

Cite
Chung KS, Congleton JG, Cummings WJ, et al. Multinucleon effects in muon capture on 3He at high energy transfer. Phys Rev C Nucl Phys. 1994;50(4):1771-1786doi: 10.1103/physrevc.50.1771.
Chung, K. S., Congleton, J. G., Cummings, W. J., Dodge, G. E., Hanna, S. S., Helmer, R., King, B. H., King, B. E., Kuhn, S. E., Lee, Y. K., Lee, J. M., Mason, G. R., Rosenzweig, D. P., Schubank, R. B., Shin, Y. M., Stevenson, N. R., & Wienands, U. (1994). Multinucleon effects in muon capture on 3He at high energy transfer. Physical review. C, Nuclear physics, 50(4), 1771-1786. https://doi.org/10.1103/physrevc.50.1771
Chung, et al. "Multinucleon effects in muon capture on 3He at high energy transfer." Physical review. C, Nuclear physics vol. 50,4 (1994): 1771-1786. doi: https://doi.org/10.1103/physrevc.50.1771
Chung KS, Congleton JG, Cummings WJ, Dodge GE, Hanna SS, Helmer R, King BH, King BE, Kuhn SE, Lee YK, Lee JM, Mason GR, Rosenzweig DP, Schubank RB, Shin YM, Stevenson NR, Wienands U. Multinucleon effects in muon capture on 3He at high energy transfer. Phys Rev C Nucl Phys. 1994 Oct;50(4):1771-1786. doi: 10.1103/physrevc.50.1771. PMID: 9969852.
Copy Download .nbib Format: NLM
Triphenyl phosphate-induced pericardial edema is associated with elevated epidermal ionocytes within zebrafish embryos.

Environmental toxicology and pharmacology

Wiegand J, Cheng V, Reddam A, Avila-Barnard S, Volz DC.
PMID: 34798236
Environ Toxicol Pharmacol. 2022 Jan;89:103776. doi: 10.1016/j.etap.2021.103776. Epub 2021 Nov 16.

Triphenyl phosphate (TPHP) is an organophosphate ester-based plasticizer and flame retardant. The objective of this study was to identify the potential role of epidermal ionocytes in mediating TPHP-induced pericardial edema within zebrafish embryos. Exposure to TPHP from 24 to...

Cite
Wiegand J, Cheng V, Reddam A, et al. Triphenyl phosphate-induced pericardial edema is associated with elevated epidermal ionocytes within zebrafish embryos. Environ Toxicol Pharmacol. 2021;89:103776doi: 10.1016/j.etap.2021.103776.
Wiegand, J., Cheng, V., Reddam, A., Avila-Barnard, S., & Volz, D. C. (2022). Triphenyl phosphate-induced pericardial edema is associated with elevated epidermal ionocytes within zebrafish embryos. Environmental toxicology and pharmacology, 89103776. https://doi.org/10.1016/j.etap.2021.103776
Wiegand, Jenna, et al. "Triphenyl phosphate-induced pericardial edema is associated with elevated epidermal ionocytes within zebrafish embryos." Environmental toxicology and pharmacology vol. 89 (2022): 103776. doi: https://doi.org/10.1016/j.etap.2021.103776
Wiegand J, Cheng V, Reddam A, Avila-Barnard S, Volz DC. Triphenyl phosphate-induced pericardial edema is associated with elevated epidermal ionocytes within zebrafish embryos. Environ Toxicol Pharmacol. 2022 Jan;89:103776. doi: 10.1016/j.etap.2021.103776. Epub 2021 Nov 16. PMID: 34798236; PMCID: PMC8724387.
Copy Download .nbib Format: NLM
From Screening to Therapy: Anti-HCV Screening and Linkage to Care in a Network of General Practitioners and a Private Gastroenterology Practice.

Pathogens (Basel, Switzerland)

Petroff D, Bätz O, Jedrysiak K, Lüllau A, Kramer J, Möller H, Heyne R, Jäger B, Berg T, Wiegand J.
PMID: 34959525
Pathogens. 2021 Dec 02;10(12). doi: 10.3390/pathogens10121570.

(1) Background: Low rates of hepatitis C virus (HCV) diagnosis and sub-optimal linkage to care constitute barriers toward eliminating the infection. In 2012/2013, we showed that HCV screening in primary care detects unknown cases. However, hepatitis C patients may...

Cite
Petroff D, Bätz O, Jedrysiak K, et al. From Screening to Therapy: Anti-HCV Screening and Linkage to Care in a Network of General Practitioners and a Private Gastroenterology Practice. Pathogens. 2021;10(12)doi: 10.3390/pathogens10121570.
Petroff, D., Bätz, O., Jedrysiak, K., Lüllau, A., Kramer, J., Möller, H., Heyne, R., Jäger, B., Berg, T., & Wiegand, J. (2021). From Screening to Therapy: Anti-HCV Screening and Linkage to Care in a Network of General Practitioners and a Private Gastroenterology Practice. Pathogens (Basel, Switzerland), 10(12), . https://doi.org/10.3390/pathogens10121570
Petroff, David, et al. "From Screening to Therapy: Anti-HCV Screening and Linkage to Care in a Network of General Practitioners and a Private Gastroenterology Practice." Pathogens (Basel, Switzerland) vol. 10,12 (2021). doi: https://doi.org/10.3390/pathogens10121570
Petroff D, Bätz O, Jedrysiak K, Lüllau A, Kramer J, Möller H, Heyne R, Jäger B, Berg T, Wiegand J. From Screening to Therapy: Anti-HCV Screening and Linkage to Care in a Network of General Practitioners and a Private Gastroenterology Practice. Pathogens. 2021 Dec 02;10(12). doi: 10.3390/pathogens10121570. PMID: 34959525.
Copy Download .nbib Format: NLM
Stabilin-1 mediates beneficial monocyte recruitment and tolerogenic macrophage programming during CVB3-induced viral myocarditis.

Journal of molecular and cellular cardiology

Carai P, Papageorgiou AP, Van Linthout S, Deckx S, Velthuis S, Lutgens E, Wijnands E, Tschöpe C, Schmuttermaier C, Kzhyshkowska J, Jones EAV, Heymans S.
PMID: 34968453
J Mol Cell Cardiol. 2021 Dec 28;165:31-39. doi: 10.1016/j.yjmcc.2021.12.009. Epub 2021 Dec 28.

Pathological innate and adaptive immune response upon viral infection may lead to cardiac injury and dysfunction. Stabilin-1 is a scavenger receptor that regulates several aspects of the innate immunity. Whether stabilin-1 affects the inflammatory response during viral myocarditis (VM)...

Cite
Carai P, Papageorgiou AP, Van Linthout S, et al. Stabilin-1 mediates beneficial monocyte recruitment and tolerogenic macrophage programming during CVB3-induced viral myocarditis. J Mol Cell Cardiol. 2021;165:31-39doi: 10.1016/j.yjmcc.2021.12.009.
Carai, P., Papageorgiou, A. P., Van Linthout, S., Deckx, S., Velthuis, S., Lutgens, E., Wijnands, E., Tschöpe, C., Schmuttermaier, C., Kzhyshkowska, J., Jones, E. A. V., & Heymans, S. (2021). Stabilin-1 mediates beneficial monocyte recruitment and tolerogenic macrophage programming during CVB3-induced viral myocarditis. Journal of molecular and cellular cardiology, 16531-39. https://doi.org/10.1016/j.yjmcc.2021.12.009
Carai, Paolo, et al. "Stabilin-1 mediates beneficial monocyte recruitment and tolerogenic macrophage programming during CVB3-induced viral myocarditis." Journal of molecular and cellular cardiology vol. 165 (2021): 31-39. doi: https://doi.org/10.1016/j.yjmcc.2021.12.009
Carai P, Papageorgiou AP, Van Linthout S, Deckx S, Velthuis S, Lutgens E, Wijnands E, Tschöpe C, Schmuttermaier C, Kzhyshkowska J, Jones EAV, Heymans S. Stabilin-1 mediates beneficial monocyte recruitment and tolerogenic macrophage programming during CVB3-induced viral myocarditis. J Mol Cell Cardiol. 2021 Dec 28;165:31-39. doi: 10.1016/j.yjmcc.2021.12.009. Epub 2021 Dec 28. PMID: 34968453.
Copy Download .nbib Format: NLM
CD11c.

Immunometabolism

Wetzels S, Bijnen M, Wijnands E, van de Gaar J, Tan A, Coort S, Biessen EAL, Schalkwijk CG, Wouters K.
PMID: 34987865
Immunometabolism. 2020 Apr 17;2(2):e200015. doi: 10.20900/immunometab20200015.

BACKGROUND: The prevalence of obesity is rising and leads to increased morbidity and mortality. Adipose tissue inflammation, due to accumulation and activation of adipose tissue macrophages (ATMs), is a key driver of this phenomenon. Macrophages are heterogeneous cells, adapting...

Cite
Wetzels S, Bijnen M, Wijnands E, et al. CD11c. Immunometabolism. 2020;2(2):e200015doi: 10.20900/immunometab20200015.
Wetzels, S., Bijnen, M., Wijnands, E., van de Gaar, J., Tan, A., Coort, S., Biessen, E. A. L., Schalkwijk, C. G., & Wouters, K. (2020). CD11c. Immunometabolism, 2(2), e200015. https://doi.org/10.20900/immunometab20200015
Wetzels, Suzan, et al. "CD11c." Immunometabolism vol. 2,2 (2020): e200015. doi: https://doi.org/10.20900/immunometab20200015
Wetzels S, Bijnen M, Wijnands E, van de Gaar J, Tan A, Coort S, Biessen EAL, Schalkwijk CG, Wouters K. CD11c. Immunometabolism. 2020 Apr 17;2(2):e200015. doi: 10.20900/immunometab20200015. PMID: 34987865; PMCID: PMC7612162.
Copy Download .nbib Format: NLM
Chest binding in context: stigma, fear, and lack of information drive negative outcomes.

Culture, health & sexuality

Peitzmeier SM, Gardner IH, Weinand J, Corbet A, Acevedo K.
PMID: 34839781
Cult Health Sex. 2021 Nov 28;1-4. doi: 10.1080/13691058.2021.1970814. Epub 2021 Nov 28.

Chest binding or 'binding' is a practice used by many trans and nonbinary people assigned a female sex at birth to achieve a flatter chest contour and affirm their gender. Binding allows individuals to affirm their gender in a...

Cite
Peitzmeier SM, Gardner IH, Weinand J, et al. Chest binding in context: stigma, fear, and lack of information drive negative outcomes. Cult Health Sex. 2021;1-4doi: 10.1080/13691058.2021.1970814.
Peitzmeier, S. M., Gardner, I. H., Weinand, J., Corbet, A., & Acevedo, K. (2021). Chest binding in context: stigma, fear, and lack of information drive negative outcomes. Culture, health & sexuality, 1-4. https://doi.org/10.1080/13691058.2021.1970814
Peitzmeier, Sarah M, et al. "Chest binding in context: stigma, fear, and lack of information drive negative outcomes." Culture, health & sexuality vol. (2021): 1-4. doi: https://doi.org/10.1080/13691058.2021.1970814
Peitzmeier SM, Gardner IH, Weinand J, Corbet A, Acevedo K. Chest binding in context: stigma, fear, and lack of information drive negative outcomes. Cult Health Sex. 2021 Nov 28;1-4. doi: 10.1080/13691058.2021.1970814. Epub 2021 Nov 28. PMID: 34839781.
Copy Download .nbib Format: NLM
NOTCH Activation via gp130/STAT3 Signaling Confers Resistance to Chemoradiotherapy.

Cancers

Koerdel K, Spitzner M, Meyer T, Engels N, Krause F, Gaedcke J, Conradi LC, Haubrock M, Beißbarth T, Leha A, Johnsen SA, Ghadimi BM, Rose-John S, Grade M, Wienands J.
PMID: 33530306
Cancers (Basel). 2021 Jan 26;13(3). doi: 10.3390/cancers13030455.

Resistance of tumor cells to chemoradiotherapy represents a fundamental problem in clinical oncology. The underlying mechanisms are actively debated. Here we show that blocking inflammatory cytokine receptor signaling via STAT3 re-sensitized treatment-refractory cancer cells and abolished tumor growth in...

Cite
Koerdel K, Spitzner M, Meyer T, et al. NOTCH Activation via gp130/STAT3 Signaling Confers Resistance to Chemoradiotherapy. Cancers (Basel). 2021;13(3)doi: 10.3390/cancers13030455.
Koerdel, K., Spitzner, M., Meyer, T., Engels, N., Krause, F., Gaedcke, J., Conradi, L. C., Haubrock, M., Beißbarth, T., Leha, A., Johnsen, S. A., Ghadimi, B. M., Rose-John, S., Grade, M., & Wienands, J. (2021). NOTCH Activation via gp130/STAT3 Signaling Confers Resistance to Chemoradiotherapy. Cancers, 13(3), . https://doi.org/10.3390/cancers13030455
Koerdel, Kristin, et al. "NOTCH Activation via gp130/STAT3 Signaling Confers Resistance to Chemoradiotherapy." Cancers vol. 13,3 (2021). doi: https://doi.org/10.3390/cancers13030455
Koerdel K, Spitzner M, Meyer T, Engels N, Krause F, Gaedcke J, Conradi LC, Haubrock M, Beißbarth T, Leha A, Johnsen SA, Ghadimi BM, Rose-John S, Grade M, Wienands J. NOTCH Activation via gp130/STAT3 Signaling Confers Resistance to Chemoradiotherapy. Cancers (Basel). 2021 Jan 26;13(3). doi: 10.3390/cancers13030455. PMID: 33530306; PMCID: PMC7865718.
Copy Download .nbib Format: NLM
Stabilin-1 mediates beneficial monocyte recruitment and tolerogenic macrophage programming during CVB3-induced viral myocarditis.

Journal of molecular and cellular cardiology

Carai P, Papageorgiou AP, Van Linthout S, Deckx S, Velthuis S, Lutgens E, Wijnands E, Tschöpe C, Schmuttermaier C, Kzhyshkowska J, Jones EAV, Heymans S.
PMID: 34968453
J Mol Cell Cardiol. 2021 Dec 28;165:31-39. doi: 10.1016/j.yjmcc.2021.12.009. Epub 2021 Dec 28.

Pathological innate and adaptive immune response upon viral infection may lead to cardiac injury and dysfunction. Stabilin-1 is a scavenger receptor that regulates several aspects of the innate immunity. Whether stabilin-1 affects the inflammatory response during viral myocarditis (VM)...

Cite
Carai P, Papageorgiou AP, Van Linthout S, et al. Stabilin-1 mediates beneficial monocyte recruitment and tolerogenic macrophage programming during CVB3-induced viral myocarditis. J Mol Cell Cardiol. 2021;165:31-39doi: 10.1016/j.yjmcc.2021.12.009.
Carai, P., Papageorgiou, A. P., Van Linthout, S., Deckx, S., Velthuis, S., Lutgens, E., Wijnands, E., Tschöpe, C., Schmuttermaier, C., Kzhyshkowska, J., Jones, E. A. V., & Heymans, S. (2021). Stabilin-1 mediates beneficial monocyte recruitment and tolerogenic macrophage programming during CVB3-induced viral myocarditis. Journal of molecular and cellular cardiology, 16531-39. https://doi.org/10.1016/j.yjmcc.2021.12.009
Carai, Paolo, et al. "Stabilin-1 mediates beneficial monocyte recruitment and tolerogenic macrophage programming during CVB3-induced viral myocarditis." Journal of molecular and cellular cardiology vol. 165 (2021): 31-39. doi: https://doi.org/10.1016/j.yjmcc.2021.12.009
Carai P, Papageorgiou AP, Van Linthout S, Deckx S, Velthuis S, Lutgens E, Wijnands E, Tschöpe C, Schmuttermaier C, Kzhyshkowska J, Jones EAV, Heymans S. Stabilin-1 mediates beneficial monocyte recruitment and tolerogenic macrophage programming during CVB3-induced viral myocarditis. J Mol Cell Cardiol. 2021 Dec 28;165:31-39. doi: 10.1016/j.yjmcc.2021.12.009. Epub 2021 Dec 28. PMID: 34968453.
Copy Download .nbib Format: NLM
Stabilin-1 mediates beneficial monocyte recruitment and tolerogenic macrophage programming during CVB3-induced viral myocarditis.

Journal of molecular and cellular cardiology

Carai P, Papageorgiou AP, Van Linthout S, Deckx S, Velthuis S, Lutgens E, Wijnands E, Tschöpe C, Schmuttermaier C, Kzhyshkowska J, Jones EAV, Heymans S.
PMID: 34968453
J Mol Cell Cardiol. 2021 Dec 27; doi: 10.1016/j.yjmcc.2021.12.009. Epub 2021 Dec 27.

Pathological innate and adaptive immune response upon viral infection may lead to cardiac injury and dysfunction. Stabilin-1 is a scavenger receptor that regulates several aspects of the innate immunity. Whether stabilin-1 affects the inflammatory response during viral myocarditis (VM)...

Cite
Carai P, Papageorgiou AP, Van Linthout S, et al. Stabilin-1 mediates beneficial monocyte recruitment and tolerogenic macrophage programming during CVB3-induced viral myocarditis. J Mol Cell Cardiol. 2021;doi: 10.1016/j.yjmcc.2021.12.009.
Carai, P., Papageorgiou, A. P., Van Linthout, S., Deckx, S., Velthuis, S., Lutgens, E., Wijnands, E., Tschöpe, C., Schmuttermaier, C., Kzhyshkowska, J., Jones, E. A. V., & Heymans, S. (2021). Stabilin-1 mediates beneficial monocyte recruitment and tolerogenic macrophage programming during CVB3-induced viral myocarditis. Journal of molecular and cellular cardiology, . https://doi.org/10.1016/j.yjmcc.2021.12.009
Carai, Paolo, et al. "Stabilin-1 mediates beneficial monocyte recruitment and tolerogenic macrophage programming during CVB3-induced viral myocarditis." Journal of molecular and cellular cardiology vol. (2021). doi: https://doi.org/10.1016/j.yjmcc.2021.12.009
Carai P, Papageorgiou AP, Van Linthout S, Deckx S, Velthuis S, Lutgens E, Wijnands E, Tschöpe C, Schmuttermaier C, Kzhyshkowska J, Jones EAV, Heymans S. Stabilin-1 mediates beneficial monocyte recruitment and tolerogenic macrophage programming during CVB3-induced viral myocarditis. J Mol Cell Cardiol. 2021 Dec 27; doi: 10.1016/j.yjmcc.2021.12.009. Epub 2021 Dec 27. PMID: 34968453.
Copy Download .nbib Format: NLM
Prospective, Noninterventional Study of Nivolumab in Real-world Patients With Locally Advanced or Metastatic Non-small Cell Lung Cancer After Prior Chemotherapy (ENLARGE-Lung).

Journal of immunotherapy (Hagerstown, Md. : 1997)

Sebastian M, Gröschel A, Gütz S, Schulz H, Müller-Huesmann H, Liersch R, von der Heyde E, Wiegand J, Ukena D, Bargon J, Schütte W, Riera-Knorrenschild J, Fischer JR, Griesinger F, Allan V, Waldenberger D, Schumann C.
PMID: 34908007
J Immunother. 2021 Dec 15; doi: 10.1097/CJI.0000000000000397. Epub 2021 Dec 15.

Nivolumab was the first immune checkpoint inhibitor approved for use in advanced non-small cell lung cancer (NSCLC). This noninterventional, prospective cohort study investigates real-world effectiveness of nivolumab in pretreated NSCLC patients in Germany (Enlarge-Lung/CA209-580). Patients with squamous (SQ) or...

Cite
Sebastian M, Gröschel A, Gütz S, et al. Prospective, Noninterventional Study of Nivolumab in Real-world Patients With Locally Advanced or Metastatic Non-small Cell Lung Cancer After Prior Chemotherapy (ENLARGE-Lung). J Immunother. 2021;doi: 10.1097/CJI.0000000000000397.
Sebastian, M., Gröschel, A., Gütz, S., Schulz, H., Müller-Huesmann, H., Liersch, R., von der Heyde, E., Wiegand, J., Ukena, D., Bargon, J., Schütte, W., Riera-Knorrenschild, J., Fischer, J. R., Griesinger, F., Allan, V., Waldenberger, D., & Schumann, C. (2021). Prospective, Noninterventional Study of Nivolumab in Real-world Patients With Locally Advanced or Metastatic Non-small Cell Lung Cancer After Prior Chemotherapy (ENLARGE-Lung). Journal of immunotherapy (Hagerstown, Md. : 1997), . https://doi.org/10.1097/CJI.0000000000000397
Sebastian, Martin, et al. "Prospective, Noninterventional Study of Nivolumab in Real-world Patients With Locally Advanced or Metastatic Non-small Cell Lung Cancer After Prior Chemotherapy (ENLARGE-Lung)." Journal of immunotherapy (Hagerstown, Md. : 1997) vol. (2021). doi: https://doi.org/10.1097/CJI.0000000000000397
Sebastian M, Gröschel A, Gütz S, Schulz H, Müller-Huesmann H, Liersch R, von der Heyde E, Wiegand J, Ukena D, Bargon J, Schütte W, Riera-Knorrenschild J, Fischer JR, Griesinger F, Allan V, Waldenberger D, Schumann C. Prospective, Noninterventional Study of Nivolumab in Real-world Patients With Locally Advanced or Metastatic Non-small Cell Lung Cancer After Prior Chemotherapy (ENLARGE-Lung). J Immunother. 2021 Dec 15; doi: 10.1097/CJI.0000000000000397. Epub 2021 Dec 15. PMID: 34908007.
Copy Download .nbib Format: NLM
The Fatty Liver Assessment in Germany (FLAG) cohort study identifies large heterogeneity in NAFLD care.

JHEP reports : innovation in hepatology

Hofmann WP, Buggisch P, Schubert L, Dikopoulos N, Schwenzer J, Muche M, Felten G, Heyne R, Ingiliz P, Schmidt A, Stein K, Wedemeyer H, Berg T, Wiegand J, Lammert F, Zeuzem S, Schattenberg JM.
PMID: 32964201
JHEP Rep. 2020 Aug 04;2(6):100168. doi: 10.1016/j.jhepr.2020.100168. eCollection 2020 Dec.

BACKGROUND & AIMS: NAFLD is a growing health concern. The aim of the Fatty Liver Assessment in Germany (FLAG) study was to assess disease burden and provide data on the standard of care from secondary care.METHODS: The FLAG study...

Cite
Hofmann WP, Buggisch P, Schubert L, et al. The Fatty Liver Assessment in Germany (FLAG) cohort study identifies large heterogeneity in NAFLD care. JHEP Rep. 2020;2(6):100168doi: 10.1016/j.jhepr.2020.100168.
Hofmann, W. P., Buggisch, P., Schubert, L., Dikopoulos, N., Schwenzer, J., Muche, M., Felten, G., Heyne, R., Ingiliz, P., Schmidt, A., Stein, K., Wedemeyer, H., Berg, T., Wiegand, J., Lammert, F., Zeuzem, S., & Schattenberg, J. M. (2020). The Fatty Liver Assessment in Germany (FLAG) cohort study identifies large heterogeneity in NAFLD care. JHEP reports : innovation in hepatology, 2(6), 100168. https://doi.org/10.1016/j.jhepr.2020.100168
Hofmann, Wolf Peter, et al. "The Fatty Liver Assessment in Germany (FLAG) cohort study identifies large heterogeneity in NAFLD care." JHEP reports : innovation in hepatology vol. 2,6 (2020): 100168. doi: https://doi.org/10.1016/j.jhepr.2020.100168
Hofmann WP, Buggisch P, Schubert L, Dikopoulos N, Schwenzer J, Muche M, Felten G, Heyne R, Ingiliz P, Schmidt A, Stein K, Wedemeyer H, Berg T, Wiegand J, Lammert F, Zeuzem S, Schattenberg JM. The Fatty Liver Assessment in Germany (FLAG) cohort study identifies large heterogeneity in NAFLD care. JHEP Rep. 2020 Aug 04;2(6):100168. doi: 10.1016/j.jhepr.2020.100168. eCollection 2020 Dec. PMID: 32964201; PMCID: PMC7490844.
Copy Download .nbib Format: NLM
Efficiently Restored Thrombopoietin Production by Ashwell-Morell Receptor and IL-6R Induced Janus Kinase 2/Signal Transducer and Activator of Transcription Signaling Early After Partial Hepatectomy.

Hepatology (Baltimore, Md.)

Reusswig F, Fazel Modares N, Brechtenkamp M, Wienands L, Krüger I, Behnke K, Lee-Sundlov MM, Herebian D, Scheller J, Hoffmeister KM, Häussinger D, Elvers M.
PMID: 33369745
Hepatology. 2021 Jul;74(1):411-427. doi: 10.1002/hep.31698. Epub 2021 Jun 04.

BACKGROUND AND AIMS: Thrombocytopenia has been described in most patients with acute and chronic liver failure. Decreased platelet production and decreased half-life of platelets might be a consequence of low levels of thrombopoietin (TPO) in these patients. Platelet production...

Cite
Reusswig F, Fazel Modares N, Brechtenkamp M, et al. Efficiently Restored Thrombopoietin Production by Ashwell-Morell Receptor and IL-6R Induced Janus Kinase 2/Signal Transducer and Activator of Transcription Signaling Early After Partial Hepatectomy. Hepatology. 2021;74(1):411-427doi: 10.1002/hep.31698.
Reusswig, F., Fazel Modares, N., Brechtenkamp, M., Wienands, L., Krüger, I., Behnke, K., Lee-Sundlov, M. M., Herebian, D., Scheller, J., Hoffmeister, K. M., Häussinger, D., & Elvers, M. (2021). Efficiently Restored Thrombopoietin Production by Ashwell-Morell Receptor and IL-6R Induced Janus Kinase 2/Signal Transducer and Activator of Transcription Signaling Early After Partial Hepatectomy. Hepatology (Baltimore, Md.), 74(1), 411-427. https://doi.org/10.1002/hep.31698
Reusswig, Friedrich, et al. "Efficiently Restored Thrombopoietin Production by Ashwell-Morell Receptor and IL-6R Induced Janus Kinase 2/Signal Transducer and Activator of Transcription Signaling Early After Partial Hepatectomy." Hepatology (Baltimore, Md.) vol. 74,1 (2021): 411-427. doi: https://doi.org/10.1002/hep.31698
Reusswig F, Fazel Modares N, Brechtenkamp M, Wienands L, Krüger I, Behnke K, Lee-Sundlov MM, Herebian D, Scheller J, Hoffmeister KM, Häussinger D, Elvers M. Efficiently Restored Thrombopoietin Production by Ashwell-Morell Receptor and IL-6R Induced Janus Kinase 2/Signal Transducer and Activator of Transcription Signaling Early After Partial Hepatectomy. Hepatology. 2021 Jul;74(1):411-427. doi: 10.1002/hep.31698. Epub 2021 Jun 04. PMID: 33369745; PMCID: PMC8236498.
Copy Download .nbib Format: NLM
Showing 13 to 24 of 132 entries